BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16777096)

  • 1. Anisakis simplex: the activity of larval products on the complement system.
    García-Hernández P; Rodero M; Cuéllar C
    Exp Parasitol; 2007 Jan; 115(1):1-8. PubMed ID: 16777096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the effect of Anisakis simplex larval products on the early and late components in the classical complement pathway.
    García-Hernández P; Rodero M; Cuéllar C
    J Parasitol; 2009 Feb; 95(1):240-1. PubMed ID: 18576871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a streptococcal preparation on the complement system.
    Kato H; Yokoe N; Matsumura N; Nishida K; Ikezaki M; Hosokawa K; Hotta T; Takemura S; Yoshikawa T; Kondo M
    Jpn J Exp Med; 1979 Oct; 49(5):343-50. PubMed ID: 529490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracts of airborne grain dusts activate alternative and classical complement pathways.
    Olenchock SA; Mull JC; Major PC
    Ann Allergy; 1980 Jan; 44(1):23-8. PubMed ID: 6766283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose intravenous immunoglobulin does not affect complement-bacteria interactions.
    Wagner E; Platt JL; Frank MM
    J Immunol; 1998 Feb; 160(4):1936-43. PubMed ID: 9469456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-complement effects of lactoferrin-derived peptides.
    Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
    Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of IL-4-like molecules in larval excretory-secretory products and crude extracts from Anisakis simplex.
    Cuéllar C; Perteguer MJ; Rodero M
    Scand J Immunol; 2001 May; 53(5):483-8. PubMed ID: 11309156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
    Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Threshold mechanism of the control of cascade proteolysis].
    Shcherbak IG
    Bioorg Khim; 1998 May; 24(5):364-9. PubMed ID: 9661790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotherapy of primary rat mammary carcinoma: inhibition by ethylenedinitrilotetraacetic acid but not by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid.
    Nakanishi K; Zbar B; Borsos T; Glenn G
    Cancer Res; 1986 Aug; 46(8):3886-90. PubMed ID: 3089581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the extract of the tamarind (Tamarindus indica) fruit on the complement system: studies in vitro and in hamsters submitted to a cholesterol-enriched diet.
    Landi Librandi AP; Chrysóstomo TN; Azzolini AE; Recchia CG; Uyemura SA; de Assis-Pandochi AI
    Food Chem Toxicol; 2007 Aug; 45(8):1487-95. PubMed ID: 17383788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of some hydroxycoumarins on complement-mediated hemolysis in human serum.
    Ivanovska N; Yossifova T; Vassileva E; Kostova I
    Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):557-62. PubMed ID: 7760580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.
    Bertazzi DT; de Assis-Pandochi AI; Talhaferro VL; Caleiro Seixas Azzolini AE; Pereira Crott LS; Arantes EC
    Int Immunopharmacol; 2005 Jun; 5(6):1077-84. PubMed ID: 15829423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
    Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
    Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-complementary effect of polysaccharide B3-PS1 in Herba Scutellariae Barbatae (Scutellaria barbata).
    Wu Y; Chen DF
    Immunopharmacol Immunotoxicol; 2009; 31(4):696-701. PubMed ID: 19874244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
    Galebskaia LV; Solovtsova IL; Riumina EV
    Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complement system. Activation, modulation, and clinical relevance.
    Lim HW
    Dermatol Clin; 1990 Oct; 8(4):609-18. PubMed ID: 2249355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.